Dergiler / Kafkas Üniversitesi Veteriner Fakültesi Dergisi / 2020 / Cilt: 26 - Sayı: 3

Immunohistochemical Distributions of HGF and PCNA in the Kidneys of Diabetic and Non-Diabetic Mice

Sayfa
321–327
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The reason for the latter result was thought to be based on the increase of mesangial cells in the glomeruli.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Diabetes mellitus is a systemic disease that causes functional disorders in various organs and systems.
📊
Temel Bulgular & Veri:STZ (100 mg/ kg) was administered intraperitoneally (ip) for the development of diabetes.
💡
Sonuç & Katkı:The reason for the latter result was thought to be based on the increase of mesangial cells in the glomeruli.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Diabetes mellitus is a systemic disease that causes functional disorders in various organs and systems. In this study, we investigated the immunohistochemical localization of hepatocyte growth factor (HGF) and proliferating cell nuclear antigen (PCNA) in the kidneys of streptozocin (STZ)-induced diabetic mice. Twenty-four Swiss albino mice were divided into three groups: control, sham and diabetic groups. STZ (100 mg/ kg) was administered intraperitoneally (ip) for the development of diabetes. The avidin-biotin-peroxidase complex (ABC) technique was used to determine HGF and PCNA immunoreactivity. In diabetic kidney tissue, there was hydropic degeneration and irregularities on the epithelium of some proximal and distal tubules. Narrowing was observed in some of the Bowman’s spaces. HGF and PCNA immunoreactivities were especially intense in the inner cortex and weak in the medulla. More intense HGF and PCNA immunoreactivities were found in the individual epithelial cells of the proximal and distal tubules. Immunoreactivities were stronger in the proximal tubules than in the distal tubules. In addition, HGF and PCNA immunoreactivities were strong in both interstitial regions and papillary ducts. HGF immunoreactivity was weaker in the diabetic group compared to the other groups. PCNA immunoreactivity generally decreased in the diabetic group but increased in the glomeruli of this group. The reason for the latter result was thought to be based on the increase of mesangial cells in the glomeruli.

🔖

Bu Makaleye Atıf Yap

DEPREM, T., AKSU, S. İ., TAŞÇI, S. K., ASLAN, Ş., BİNGÖL, S. A., GÜLMEZ, N. (2020). Immunohistochemical Distributions of HGF and PCNA in the Kidneys of Diabetic and Non-Diabetic Mice. Kafkas Üniversitesi Veteriner Fakültesi Dergisi, Cilt: 26 - Sayı: 3, 321–327. https://ajindex.com/articles/180554

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. American Diabetes Association (ADA): Diagnosis and classification of diabetes mellitus. Diabetes Care, 35, S64-S71, 2012 2. Kharroubi AT, Darwish HM: Diabetes mellitus: The epidemic of the century. World J Diabetes, 6 (6): 850-867, 2015. DOI: 10.4239/wjd.v6.i6.850 3. Al-awar A, Kupai K, Veszelka M, Szucs G, Attieh Z, Murlasits Z, Török S, Pósa A, Varga C: Experimental diabetes mellitus in different animal models. J Diabetes Res 2016:9051426, 2016. DOI: 10.1155/ 2016/9051426 4. Sanai T, Sobka T, Johnson T, El-Essawy M, Muchaneta-Kubara EC, Ben Gharbia O, Oldroyd S, El Nahus AM: Expression of cytoskeletal proteins during the course of experimental diabetic nephropathy. Diabetologia, 43, 91-100, 2000. DOI: 10.1007/s001250050012 5. Fajardo-Puerta AB, Prado MM, Frampton AE, Jiao LR: Gene of the month: HGF. J Clin Pathol, 69, 575-579, 2016. DOI: 10.1136/ jclinpath-2015-203575 6. Liu Y, Centracchio JN, Lin L, Sun AM, Dworkin LD: Constitutive expression of HGF modulates renal epithelial cell phenotype and induces c-met and fibronectin expression. Exp Cell Res, 242, 174-185, 1998. DOI: 10.1006/excr.1998.4107 7. Liu Y: Hepatocyte growth factor and the kidney. Curr Opin Nephrol Hypertens, 11, 23-30, 2002. 8. Barrow-McGee R, Kermorgant S: Met endosomal signalling: In the right place, at the right time. Int J Biochem Cell Biol, 49, 69-74, 2014. DOI: 10.1016/j.biocel.2014.01.009 9. Hack SP, Bruey JM, Koeppen H: HGF/MET-directed therapeutics in gastroesophageal cancer: A review of clinical and biomarker development. Oncotarget, 5, 2866-2880, 2014. DOI: 10.18632/oncotarget.2003 10. Matsumoto K, Funakoshi H, Takahashi H, Sakai K: HGF-Met pathway in regeneration and drug discovery Biomedines, 2 (4): 275–300, 2014. DOI: 10.3390/biomedicines2040275 11. Reviriego-Mendoza MM, Santy LC: The cytohesin guanosine exchange factors (GEFs) are required to promote HGF-mediated renal recovery after acute kidney injury (AKI) in mice. Physiol Rep, 3 (6): e12442, 2015. DOI: 10.14814/phy2.12442 12. Dai C, Yang J, Liu Y: Single ınjection of naked plasmid encoding hepatocyte growth factor prevents cell death and ameliorates acute renal failure in mice. J Am Soc Nephrol, 13 (2): 411-422, 2002. 13. Gervai JZ, Galicza J, Szeltner Z, Zamborszky J, Szüts D: A genetic study based on PCNA-ubiquitin fusions reveals no requirement for PCNA polyubiquitylation in DNA damage tolerance. DNA Repair, 54, 46-54, 2017. DOI: 10.1016/j.dnarep.2017.04.003 14. Boehm EM, Spies M, Washington MT: PCNA tool belts